Invitae to Appeal Trial Verdict
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the...
Source: prnewswire.com
Anchored Multiplex News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Anchored Multiplex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Anchored Multiplex Today - Breaking & Trending Today
Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc.
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it has completed a transaction with Integrated DNA Technologies,...
Source: prnewswire.com
Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of FusionPlex Dx® and LiquidPlex Dx™ in Europe, part...
Source: prnewswire.com
Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
- – New in-vitro diagnostic Kits help patients fight Cancer in the EU – SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical ...
Source: zazoom.it
Invitae Corporation: Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
- New in-vitro diagnostic kits help patients fight cancer in the EU - SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced
Source: finanznachrichten.de